Literature DB >> 705269

Neutrophil chemotaxis and serum chemotactic activity in systemic lupus erythematosus.

I Alvarez, J J Vazquez, G Fontan, A Gil, J Barbado, J A Ojeda.   

Abstract

Neutrophil chemotaxis, random motility, serum chemotactic activity derived from complement activation by classical or alternative pathways, and the presence of serum inhibitors of chemotaxis were all studied in 24 patients affected by Systemic Lupus Erythematosus (SLE) and in an equal number of healthy control subjects. Statistical comparison between patients and controls indicated lower chemotactic activity in patient's serum when activated by the classical pathway, and the presence in some SLE patients of a heat-labile inhibitor of the chemoattractants. Low "classical pathway" chemotactic indexes were correlated with low C4 values, active nephritis and recurrent infections. The presence of heat-labile inhibitor was correlated with low values of C3. Our data suggest that defective neutrophil chemotaxis could be one of the mechanisms contributing to the high incidence of infections suffered by SLE patients. The importance of conducting separate studies on cell movement and on generation of serum chemotactic activities by classical and alternative pathways in SLE patients is discussed.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 705269     DOI: 10.3109/03009747809098837

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  5 in total

1.  Staphylococcal infections in childhood dermatomyositis--association with the development of calcinosis, raised IgE concentrations and granulocyte chemotactic defect.

Authors:  E C Moore; F Cohen; S D Douglas; V Gutta
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

2.  Intracellular contents of cyclic nucleotides in neutrophils and lymphocytes from patients with systemic lupus erythematosus.

Authors:  M Shingu; K Tatsukawa; M Nobunaga
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

3.  Lessons learned from phagocytic function studies in a large cohort of patients with recurrent infections.

Authors:  Baruch Wolach; Ronit Gavrieli; Dirk Roos; Sivan Berger-Achituv
Journal:  J Clin Immunol       Date:  2011-12-30       Impact factor: 8.317

4.  Tuberculosis in patients with systemic lupus erythematosus.

Authors:  P H Feng; T H Tan
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

5.  Neutrophil function in systemic lupus erythematosus and other collagen diseases.

Authors:  H Al-Hadithy; D A Isenberg; I E Addison; A H Goldstone; M L Snaith
Journal:  Ann Rheum Dis       Date:  1982-02       Impact factor: 19.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.